Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 93.4% to $0.117 on volume of 124,152,860 shares Jaguar Health Inc. (JAGX) fell 9.0% to $0.0818 on volume of 39,020,683 shares CXApp Inc. (CXAI) rose 82.9% to $4.48 on volume of 34,784,405 shares N...
2024-03-28 23:10:02 ET Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Conference Call March 28, 2024 05:00 PM ET Company Participants Julie Gannon - Investor Relations Officer Kirk Huntsman - Chairman & Chief Executive Officer Brad Amman - Chief Financial O...
2024-03-28 17:05:52 ET More on Vivos Therapeutics Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therapeutics Read the full article on Seeking Alpha For further...
Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses Declined 27% Due to Success of Cost Cutting Initiatives Management to Host Conf...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...
LITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatment...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”))....
2024-02-15 08:17:12 ET More on Vivos Therapeutics Vivos stock rallies after FDA clears oral device treatment for severe sleep apnea Seeking Alpha’s Quant Rating on Vivos Therapeutics Read the full article on Seeking Alpha For further details see: V...
LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for ...
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including all severities of obstructive sleep apnea (“OSA”) in ...
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Expanding its Revenue Generating Initiatives As Operating Expenses Decrease 22%, Representing Seven Consecutive Quarters of Year Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo....
LITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device a...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...